Search research articles
Contact Us
Filters
Showing results (11-20 of 184) with videos related to
Page
of 19
Sort By:
Chemistry and Physics of Lipids
|
December 7, 2000
A historical overview of chemical research on cannabinoids
R Mechoulam, L Hanus
Progress in Lipid Research
|
February 8, 2011
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P Pacher, R Mechoulam
Molecular Neurobiology
|
October 24, 2007
Endocannabinoids and traumatic brain injury
R Mechoulam, E Shohami
European Journal of Pharmacology
|
February 9, 1993
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
E Fride, R Mechoulam
Pain Research & Management
|
February 21, 2002
The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection
R Mechoulam, L Hanu
The International Journal of Neuropsychopharmacology
|
April 3, 2001
Comment on 'Health aspects of cannabis: revisited' (Hollister)
R. Mechoulam, D. Golan
Nature
|
April 12, 2001
Physiology. A hunger for cannabinoids
R Mechoulam, E Fride
Carbohydrate Research
|
December 1, 1981
O-and C-D-glucosyluronic acid derivatives of delta 1-tetrahydrocannabinol: synthesis and differential behavior to beta-glucuronidase
U Zehavi, R Mechoulam
Brain Research. Developmental Brain Research
|
August 20, 1996
Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice
E Fride, R Mechoulam
NIDA Research Monograph
|
January 1, 1987
Anticonvulsant and neurotoxic effects of tetrahydrocannabinol stereoisomers
P Consroe, R Mechoulam
Page
of 19
Search research articles
Search
Showing results (11-20 of 184) with videos related to
Sort By:
Page
of 19
Chemistry and Physics of Lipids
|
December 7, 2000
A historical overview of chemical research on cannabinoids
R Mechoulam, L Hanus
Progress in Lipid Research
|
February 8, 2011
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P Pacher, R Mechoulam
Molecular Neurobiology
|
October 24, 2007
Endocannabinoids and traumatic brain injury
R Mechoulam, E Shohami
European Journal of Pharmacology
|
February 9, 1993
Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
E Fride, R Mechoulam
Pain Research & Management
|
February 21, 2002
The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection
R Mechoulam, L Hanu
The International Journal of Neuropsychopharmacology
|
April 3, 2001
Comment on 'Health aspects of cannabis: revisited' (Hollister)
R. Mechoulam, D. Golan
Nature
|
April 12, 2001
Physiology. A hunger for cannabinoids
R Mechoulam, E Fride
Carbohydrate Research
|
December 1, 1981
O-and C-D-glucosyluronic acid derivatives of delta 1-tetrahydrocannabinol: synthesis and differential behavior to beta-glucuronidase
U Zehavi, R Mechoulam
Brain Research. Developmental Brain Research
|
August 20, 1996
Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice
E Fride, R Mechoulam
NIDA Research Monograph
|
January 1, 1987
Anticonvulsant and neurotoxic effects of tetrahydrocannabinol stereoisomers
P Consroe, R Mechoulam
Page
of 19